Research progress in the protective efficacy of human papillomavirus vaccines in males
10.3760/cma.j.cn112309-20221117-00381
- VernacularTitle:人乳头瘤病毒疫苗在男性人群中的保护效果研究进展
- Author:
Yahui WANG-JIANG
1
;
Zhaofeng BI
;
Shoujie HUANG
;
Ting WU
;
Yingying SU
Author Information
1. 厦门大学公共卫生学院，国家传染病诊断试剂与疫苗工程技术研究中心，厦门 361102
- Keywords:
Human papillomavirus;
Vaccine;
Males;
Protective efficacy;
Genital warts;
Genital neoplasm
- From:
Chinese Journal of Microbiology and Immunology
2023;43(6):485-492
- CountryChina
- Language:Chinese
-
Abstract:
Human papillomavirus (HPV) is one of the most common sexually transmitted pathogens. It can cause a variety of diseases such as condyloma acuminatum, anal cancer, penile cancer and oropharyngeal cancer in men, resulting in a high disease burden. With the development of society, the application of HPV vaccines in males has attracted more attention. Currently, there are many clinical trials and real-world research results of HPV vaccines applied to boys and men worldwide, and many countries have introduced HPV vaccination for underage boys into their national immunization programs. This article intended to review the research progress in the efficacy of HPV vaccines in male population.
